type_of_cancer: brca
cancer_study_identifier: brca_mskcc_solitd_5065_g
name: Study of BYL719 with Letrozole in ER+/EGFR2- Breast Cancer Patients - Solit (CMO 5065_g)
date_of_last_update: 2015-03-25
description: Genetic profiling of a mix of non-responders and responders to combination therapy in metastatic breast cancer patients (updated on 2015-03-25)
groups: COMPONC;SOLITD
short_name: BRCA (CMO 5065_g)
